Achieved Record Revenue for 2024 and Growth of 31%;

Reduced 2024 Operational Cash Burn by 35%

Strategic Initiatives Fuel Accelerated Growth in Orders and Active Customers

Cost Discipline and Targeted Marketing Drive Further Operational Efficiency Gains

Revenue of $11.2M and Positive Adjusted EBITDA for Seventh Consecutive Quarter

Strengthened Balance Sheet and improved financial position

Significant Progress in Closing EXIM and Bank Financing to support US Manufacturing Expansion and Overall Growth Plans

Reaffirms Fiscal 2025 Revenue Guidance Exceeding $60M, Driven by Strong Order Pipeline

Net income of $0.8 million

Adjusted EBITDA¹ of $1.3 million

Pediatric Portfolio net revenue up 86% sequentially

First quarterly sequential prescription increase for both ADHD and Pediatric portfolios since Q2 fiscal 2023

$20.4 million cash balance at December 31, 2024

Company to host conference call and webcast today, February 12, 2025, at 4:30 p.m. Eastern time

Digital Employee Experience (DEX) Leader Achieved Multiple Milestones and 30% Global ARR Growth

Revenue of $44.6M with $4M Adjusted EBITDA1 (6th Consecutive Positive Quarter)

Historic Positive Cash Flow from Operations and Improved Gross Margins

Approval of $51million direct loan from The Export-Import Bank of the United States expected to fund Electrovaya's lithium ion cell and battery manufacturing facility in Jamestown, New York

Removal of Going Concern note in the financial statements due to improved financial performance

Net income of $1.5 million

Adjusted EBITDA¹ of $1.9 million

ADHD Portfolio net revenue up 1% to $15.3 million

Pediatric Portfolio net revenue up 54% sequentially

$20.1 million cash balance at September 30, 2024

Organizational changes and operating optimization plan implemented to further streamline operations, reduce expenses, and accelerate path to consistent cash flow

Ryan Selhorn promoted to Chief Financial Officer

Company to host conference call and webcast today, November 13, 2024, at 4:30 p.m. Eastern time

Achieved Record Revenue and Growth of 41%; Operational Cash Burn Reduced to $1.2 Million